NCT05397496
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05397496
Title Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ISR | FRA | ESP | BEL

Facility Status City State Zip Country Details
University Of Miami Miami Florida 33136 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
The University of Kansas Clinical Research Ctr Fairway Kansas 66205 United States Details
Memorial Sloan Kettering Cancer Ctr New York New York 10065 United States Details
Oregon Health Sciences University Portland Oregon 97239 United States Details
Novartis Investigative Site Ghent 9000 Belgium Details
Novartis Investigative Site Beijing 100730 China Details
Novartis Investigative Site Shanghai 200032 China Details
Novartis Investigative Site Tianjin 300020 China Details
Novartis Investigative Site Créteil 94010 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Reggio Emilia RE 42123 Italy Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Barcelona Catalonia 08035 Spain Details
Novartis Investigative Site Barcelona 08036 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field